About the Ductal Carcinoma Session
Ductal carcinoma is a prevalent form of breast cancer that originates in the milk ducts, comprising a significant portion of breast cancer diagnoses. Cancer research has delved into understanding its molecular mechanisms, risk factors, and treatment options. Studies highlight the role of genetic mutations, such as BRCA1 and BRCA2, in predisposing individuals to ductal carcinoma. Moreover, advancements in imaging techniques like MRI and molecular profiling have improved early detection and personalized treatment strategies. Targeted therapies, such as HER2 inhibitors and hormone therapies, have shown promising results in managing ductal carcinoma, enhancing survival rates, and reducing recurrence. Ongoing research aims to further elucidate the complexities of this disease, paving the way for more effective interventions and improved outcomes for patients.
Topics Covered in Ductal Carcinoma
DCIS Management
Hormone Receptor Status
HER2-Targeted Therapy
BRCA Mutations
Breast MRI
Breast-Conserving Surgery
Related Scientific Sessions at CIOC 2027
Why Attend the Ductal Carcinoma Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Ductal Carcinoma work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Ductal Carcinoma research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Ductal Carcinoma track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Ductal Carcinoma Conference 2027 — FAQs
What is the Ductal Carcinoma track at CIOC 2027?
The Ductal Carcinoma track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Ductal Carcinoma. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Ductal Carcinoma sessions?
Cancer researchers and clinicians, educators and students with an interest in Ductal Carcinoma are all welcome — whether presenting or attending.
Can I present my research in the Ductal Carcinoma track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Ductal Carcinoma sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Ductal Carcinoma track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.